THIRD HOSPITAL JOINS MULTICENTER COVID-19 BVA-100® BLOOD TEST STUDY
Daxors BVA test is the first and only diagnostic test cleared by FDA that offers insights into patients capillary leak rate via its albumin tracer in addition to 98% accurate measure of plasma and red cell volume.
- Daxors BVA test is the first and only diagnostic test cleared by FDA that offers insights into patients capillary leak rate via its albumin tracer in addition to 98% accurate measure of plasma and red cell volume.
- Daxor is the global leader in blood volume measurement technology, utilized by major hospitals in the United States.
- Daxor Corporation (NYSE: DXR) is the global leader in blood volume measurement technology focused on blood volume testing innovation.
- We developed and market the BVA-100 (Blood Volume Analyzer), the first diagnostic blood test cleared by the FDA to provide safe, accurate, objective quantification of blood volume status and composition compared to patient-specific norms.